ABX-318

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameABX-318
Drug Alias NameHPV-induced uterine cervical dysplasia therapeutic vaccine (Wittycell)therapeutic vaccine (Abivax)ABX-318
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical DysplasiaPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWittycell
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbivax SaBC Cancer AgencyWittycell +[4] 
Active IndicationsN/A
Inactive IndicationsUterine Cervical DysplasiaPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A